The weekly litigation news digest is live. Subscribe now

IP Verse

Novel Tnf Structure For Use In Therapy - EP3311168

The patent EP3311168 was granted to UCB Biopharma on May 10, 2023. The application was filed on Oct 22, 2015 under application number EP15784067A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3311168

UCB BIOPHARMA
Application Number
EP15784067A
Filing Date
Oct 22, 2015
Status
Granted And Under Opposition
Apr 7, 2023
Publication Date
May 10, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DR H ULRICH DORRIESFeb 12, 2024DORRIESADMISSIBLE
DR H ULRICH DORRIESFeb 12, 2024DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2002110868
INTERNATIONAL-SEARCH-REPORTUS7993636
INTERNATIONAL-SEARCH-REPORTWO2013186229
INTERNATIONAL-SEARCH-REPORTWO2014009295
OPPOSITIONUS2002110868
OPPOSITIONUS7993636
OPPOSITIONWO2013186229
OPPOSITIONWO2014009295
OPPOSITIONWO2014009296
OPPOSITIONWO2015086525
OPPOSITIONWO2015086526
OPPOSITIONWO2015086527
OPPOSITIONWO2016149436
OPPOSITIONWO2016168633

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents